Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine

Canada
29 March 2017

NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:

  1. NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
  2. NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
  3. For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
  4. Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.

ca.png
Documents to download

Related News & Events

  • Canada

    NACI mandate expands to support local decision-making on vaccine programs

    28.07.2017

    In June 2016 the Public Health Agency of Canada (PHAC) announced that the mandate of Canada’s NITAG, the National Advisory Committee on Immunization (NACI) will be expanded. In addition to the assessment of vaccine characteristics (safety, efficacy, effectiveness, and immunogenicity), NACI will also be assessing additional programmatic elements including economic evaluations, feasibility of implementation, acceptability, ethics and equity. 

    Read more
  • NITAG training

    Read more on NITAG training in resource-constrained settings

    20.06.2019

    Antoinette Ba-Nguy and Adeel Shaah, ex-SIVAC staff and experienced NITAG trainers,  wrote an article on the NITAG trainings delivered through the Partnership for Influenza Vaccine Introduction (PIVI) program.

    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more